Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration.

Lymphatic vessels are essential for lipid absorption and transport. Despite increasing numbers of observations linking lymphatic vessels and lipids, little research has been devoted to address how dysregulation of lipid balance in the blood, ie, dyslipidemia, may affect the functional biology of lymphatic vessels. Here, we show that hypercholesterolemia occurring in apolipoprotein E-deficient (apoE(-/-)) mice is associated with tissue swelling, lymphatic leakiness, and decreased lymphatic transport of fluid and dendritic cells from tissue. Lymphatic dysfunction results in part from profound structural abnormalities in the lymphatic vasculature: namely, initial lymphatic vessels were greatly enlarged, and collecting vessels developed notably decreased smooth muscle cell coverage and changes in the distribution of lymphatic vessel endothelial hyaluronic acid receptor-1 (LYVE-1). Our results provide evidence that hypercholesterolemia in adult apoE(-/-) mice is associated with a degeneration of lymphatic vessels that leads to decreased lymphatic drainage and provides an explanation for why dendritic cell migration and, thus, immune priming, are compromised in hypercholesterolemic mice.

[1]  H Shimokawa,et al.  Primary endothelial dysfunction: atherosclerosis. , 1999, Journal of molecular and cellular cardiology.

[2]  M. Willingham,et al.  Inflammation and skin cholesterol in LDLr−/−, apoA-I−/− mice: link between cholesterol homeostasis and self-tolerance? Published, JLR Papers in Press, October 28, 2006. , 2007, Journal of Lipid Research.

[3]  A. Bollinger,et al.  Microlymphatic aneurysms in patients with lipedema. , 2001, Lymphology.

[4]  R. Erickson,et al.  Chy‐3 mice are Vegfc haploinsufficient and exhibit defective dermal superficial to deep lymphatic transition and dermal lymphatic hypoplasia , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[5]  R K Jain,et al.  Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory. , 1996, The American journal of physiology.

[6]  S. Rockson.  Literature watch. Cooke CJ, Nanjee MN, Stepanova IP, Olszewski WL, Miller NE. Variations in lipid and apolipoprotein concentrations in human leg lymph: effects of posture and physical exercise. Atherosclerosis 2004; 173:39-45. , 2004, Lymphatic research and biology.

[7]  Guillermo Oliver,et al.  Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity , 2005, Nature Genetics.

[8]  E. Fisher,et al.  Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. , 2003, Atherosclerosis.

[9]  M. Netea,et al.  Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice , 1997, Infection and immunity.

[10]  F. Blei.  Literature watch. Dellinger, MT, RJ Hunter, et al. (2007). Chy-3 mice are Vegfc haploinsufficient and exhibit defective dermal superficial to deep lymphatic transition and dermal lymphatic hypoplasia. Dev Dyn 236:2346-2355. , 2007, Lymphatic research and biology.

[11]  M. Detmar,et al.  Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis. , 2009, The Journal of investigative dermatology.

[12]  K. Alitalo,et al.  Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation , 2007, Nature Medicine.

[13]  W. Paulus,et al.  Nitric oxide and cardiac contractility in human heart failure: time for reappraisal. , 2001, Circulation.

[14]  M. Salmon,et al.  A Chemokine-Dependent Stromal Induction Mechanism for Aberrant Lymphocyte Accumulation and Compromised Lymphatic Return in Rheumatoid Arthritis , 2005, The Journal of Immunology.

[15]  M. Swartz,et al.  Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. , 2006, Microvascular research.

[16]  T. Funahashi,et al.  Clinical features of familial hypercholesterolemia. , 1989, Arteriosclerosis.

[17]  K. Alitalo,et al.  Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis , 2004, Nature Medicine.

[18]  M. Netea,et al.  Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. , 1999, Journal of lipid research.

[19]  S Bilancini,et al.  Functional Lymphatic Alterations in Patients Suffering from Lipedema , 1995, Angiology.

[20]  PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. , 2005, Genes & development.

[21]  R. Morishita,et al.  Vascular protective effects of ezetimibe in ApoE-deficient mice. , 2009, Atherosclerosis.

[22]  Elisabetta Dejana,et al.  Functionally specialized junctions between endothelial cells of lymphatic vessels , 2007, The Journal of experimental medicine.

[23]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  D. Schmechel,et al.  Altered immune responses in apolipoprotein E-deficient mice. , 2000, Journal of lipid research.

[25]  S. Reddy,et al.  Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells. , 2006, American journal of physiology. Heart and circulatory physiology.

[26]  W. Olszewski,et al.  Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids. , 2001, Journal of lipid research.

[27]  P. Elias,et al.  Apolipoprotein E deficiency leads to cutaneous foam cell formation in mice. , 1995, The Journal of investigative dermatology.

[28]  D. Jäger,et al.  The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes , 2000, Cell.

[29]  J. Breslow.  Mouse Models of Atherosclerosis , 1996, Science.

[30]  R K Jain,et al.  Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation. , 1999, Journal of biomechanics.

[31]  L. Havekes,et al.  Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding. , 1995, Atherosclerosis.

[32]  C. Harwood,et al.  Causes and clinical manifestations of lymphatic failure. , 1995, Clinics in dermatology.

[33]  R. Schwartz,et al.  Lymphedema: an immunologically vulnerable site for development of neoplasms. , 2002, Journal of the American Academy of Dermatology.

[34]  J. M. Janes,et al.  Idiopathic lymphedema. Review of 131 cases. , 1962, JAMA.

[35]  Cliff,et al.  An in vivo study of the microlymphatics in psoriasis using fluorescence microlymphography , 1999, The British journal of dermatology.

[36]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[37]  F. Ginhoux,et al.  B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. , 2006, Immunity.

[38]  H. Nagawa,et al.  Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma. , 2004, Cancer letters.

[39]  P. Campochiaro,et al.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. , 2002, Developmental cell.

[40]  W. Olszewski,et al.  Variations in lipid and apolipoprotein concentrations in human leg lymph: effects of posture and physical exercise. , 2004, Atherosclerosis.

[41]  M. Swartz,et al.  The physiology of the lymphatic system. , 2001, Advanced drug delivery reviews.

[42]  R. Zinkernagel,et al.  Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 , 2001, The Journal of Immunology.

[43]  D. Zawieja,et al.  Molecular Regulation of Lymphatic Contractility , 2008, Annals of the New York Academy of Sciences.

[44]  D. Jackson,et al.  An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium , 2006, The Journal of experimental medicine.

[45]  E. Fisher,et al.  Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. , 2004, Immunity.

[46]  M. Detmar,et al.  VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. , 2007, Blood.

[47]  Melody A. Swartz,et al.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels , 2005, Nature Reviews Immunology.

[48]  S. Liao,et al.  Synchrony of High Endothelial Venules and Lymphatic Vessels Revealed by Immunization1 , 2006, The Journal of Immunology.

[49]  G. Schmid-Schönbein,et al.  Microlymphatics and lymph flow. , 1990, Physiological reviews.

[50]  J. Dayer,et al.  High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? , 2002, Autoimmunity reviews.

[51]  S. Hirakawa,et al.  Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. , 2006, The American journal of pathology.